Morningstar Investor users sign in here.
We’re currently having some problems with our data feed. We apologise for any inconvenience.

Company Profile

  • Business description

    Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

  • Contact

    100 Nagog Park
    Acton MA 01720
    USA

    T: +1 978 600-7000

    E: dgordon@insulet.com

    https://www.insulet.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2024

    Employees

    3,000

Insulet Corp News & Analysis

funds

A top-tier small cap fund

Morningstar is confident Dimensional will outperform over the longer-term despite lagging during the market sell-off.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,022.70 28.50 0.36%
CAC 40 8,229.69 42.04 0.51%
DAX 40 18,788.91 102.31 0.55%
Dow JONES (US) 39,387.76 331.37 0.85%
FTSE 100 8,421.26 39.91 0.48%
HKSE 18,974.22 436.41 2.35%
NASDAQ 16,346.26 43.51 0.27%
Nikkei 225 38,229.11 155.13 0.41%
NZX 50 Index 11,755.17 8.59 0.07%
S&P 500 5,214.08 26.41 0.51%
S&P/ASX 200 7,749.00 27.40 0.35%
SSE Composite Index 3,154.55 0.23 0.01%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.04 0.00 10.00%
Imugene Ltd IMU 0.08 0.01 7.14%
Jupiter Mines Ltd JMS 0.33 0.04 11.86%
Core Lithium Ltd CXO 0.15 0.01 3.45%
De Grey Mining Ltd DEG 1.23 0.02 -1.33%
Telstra Group Ltd TLS 3.66 0.02 0.55%
Lake Resources NL LKE 0.07 0.00 4.84%
Liontown Resources Ltd LTR 1.40 0.00 0.00%
Pilbara Minerals Ltd PLS 4.14 0.03 -0.72%
Base Resources Ltd BSE 0.26 0.01 4.08%